Advanced search
Start date
Betweenand


Immunogenicity study of the HIV LAMP/gag chimera DNA vaccine in the mucosa sites of immunized mice during neonatal phase.

Full text
Author(s):
Adriana Leticia Goldoni
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI)
Defense date:
Examining board members:
Maria Notomi Sato; Valeria Aoki; Luciana Barros de Arruda; Solange Barros Carbonare; Armando Morais Ventura
Advisor: Maria Notomi Sato
Field of knowledge: Biological Sciences - Immunology
Indexed in: Banco de Dados Bibliográficos da USP-DEDALUS; Biblioteca Digital de Teses e Dissertações - USP
Location: Universidade de São Paulo. Biblioteca do Instituto de Ciências Biomédicas; T-ICB BMI QW504; G621ei
Abstract

The development of mucosal immunogenic vaccines is essential to prevent HIV infection. The LAMP/gag vaccine strategy associates the murine LAMP gene and the HIV-1 gag gene, allowing antigenic presentation in the context of MHC class II molecules. The results showed that the immunization with LAMP/gag chimera DNA vaccine induced anti-GAG sIgA and IgG antibodies and the association of intradermal injection to the intranasal immunization protocol induced anti-GAG antibodies. Both LAMP/gag and gag vaccines generated a strong CD8+ T-cell response. However, the CD4+ T cells response was more pronounced in LAMP/gag mice, able to recognized twice the number of GAG peptide pools and increasing the amplitude of IFN-<font face=\"symbol\">g and IL-4 SFC. The association of the CpG ODN adjuvant to the DNA vaccines downregulated the CD4+ T cells response and the IgG2a antibodies production. The data showed that only the LAMP/gag chimera DNA vaccine was able of inducing cellular and humoral immune responses and immunological memory due to the adequate CD4+ T cells activation. (AU)